428 related articles for article (PubMed ID: 34830836)
1. Biological Significance and Targeting of the FGFR Axis in Cancer.
Chioni AM; Grose RP
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830836
[TBL] [Abstract][Full Text] [Related]
2. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
3. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
[TBL] [Abstract][Full Text] [Related]
4. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract][Full Text] [Related]
5. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
Presta M; Chiodelli P; Giacomini A; Rusnati M; Ronca R
Pharmacol Ther; 2017 Nov; 179():171-187. PubMed ID: 28564583
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
8. Targeting the fibroblast growth factor receptor family in cancer.
Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
[TBL] [Abstract][Full Text] [Related]
9. Future applications of FGF/FGFR inhibitors in cancer.
Ghedini GC; Ronca R; Presta M; Giacomini A
Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor fusions in cancer: opportunities and challenges.
Chen L; Zhang Y; Yin L; Cai B; Huang P; Li X; Liang G
J Exp Clin Cancer Res; 2021 Nov; 40(1):345. PubMed ID: 34732230
[TBL] [Abstract][Full Text] [Related]
11. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
12. FGFR signalling in women's cancers.
Fearon AE; Gould CR; Grose RP
Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
[TBL] [Abstract][Full Text] [Related]
13. Non-canonical fibroblast growth factor signalling in angiogenesis.
Murakami M; Elfenbein A; Simons M
Cardiovasc Res; 2008 May; 78(2):223-31. PubMed ID: 18056763
[TBL] [Abstract][Full Text] [Related]
14. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers.
Shan KS; Dalal S; Thaw Dar NN; McLish O; Salzberg M; Pico BA
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255923
[TBL] [Abstract][Full Text] [Related]
15. Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions.
Repetto M; Crimini E; Giugliano F; Morganti S; Belli C; Curigliano G
Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1233-1252. PubMed ID: 34591728
[No Abstract] [Full Text] [Related]
16. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network.
Xu R; Rudd TR; Hughes AJ; Siligardi G; Fernig DG; Yates EA
FEBS J; 2013 May; 280(10):2260-70. PubMed ID: 23441759
[TBL] [Abstract][Full Text] [Related]
17. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptors and their ligands in the adult rat kidney.
Cancilla B; Davies A; Cauchi JA; Risbridger GP; Bertram JF
Kidney Int; 2001 Jul; 60(1):147-55. PubMed ID: 11422746
[TBL] [Abstract][Full Text] [Related]
19. De-regulated FGF receptors as therapeutic targets in cancer.
Knights V; Cook SJ
Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
[TBL] [Abstract][Full Text] [Related]
20. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
